Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Fudan University Shanghai Cancer Center · Shanghai

Dr. Liu Yizhen刘一臻

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

LY

Professional overview

Dr. Liu Yizhen is a Chief Physician and Professor in the Department of Medical Oncology at Fudan University Shanghai Cancer Center. Clinical work focuses on chemotherapy, targeted therapy, and immunotherapy for lymphoma.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic rolesProfessor
DepartmentDepartment of Medical Oncology
HospitalFudan University Shanghai Cancer Center
CityShanghai

Areas of focus

LymphomaChemotherapy, targeted therapy, and immunotherapy

Experience & recognition

  • Secretary-General of the Youth Committee of the Shanghai Anti-Cancer Association
  • Principal investigator of 2 National Natural Science Foundation of China (NSFC) grants and 1 Shanghai Municipal Health Commission Youth Fund grant
  • First or corresponding author of over 10 SCI papers
  • Outstanding Graduate of Beijing Municipality
  • Outstanding Xinjiang Aid Expert

Professional roles

  • Youth Committee Member, National Lymphoma Quality Control Expert Committee
  • Member, Lymphoma Branch of the Chinese Medical Education Association
  • Member, Shanghai Tumor Chemotherapy Quality Control Expert Group
  • Secretary-General, Youth Committee of the Shanghai Anti-Cancer Association
  • Member, Integrated Traditional Chinese and Western Medicine Lymphoma Professional Committee

Frequently asked questions

What does Dr. Liu Yizhen specialize in?

Chemotherapy, targeted therapy, and immunotherapy for lymphoma

Which hospital and department is Dr. Liu Yizhen in?

Department of Medical Oncology at Fudan University Shanghai Cancer Center

Sources

Dr. Liu Yizhen has not reviewed this page.